Skip to main content
Log in

Absorption rate and bioavailability of valproic acid and its sodium salt from rectal dosage forms

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Rectal and oral absorption of valproic acid and its sodium salt by man were compared to explore the possibility of rectal administration of the drug. The plasma concentration of valproic acid was measured by gas chromatography after a single oral dose of sodium valproate 600 mg, and after single rectal doses of sodium valproate 600 mg and valproic acid 520 mg, in a cross-over study in 7 volunteers. The rectal dosage forms included fatty suppositories and aqueous solutions. Compared with oral administration, rectal absorption of sodium valproate from an aqueous micro-enema was fast and complete. The free acid was absorbed more rapidly from fatty suppositories than was the sodium salt. The absorption rate from the rectum increased with the dose of valproic acid. Both findings are consistent with a diffusion — absorption mechanism based on the pH-partition hypothesis. Differences in the chemical composition of the fatty suppository base were not reflected in differences in absorption rate and relative bioavailability. No essential difference in absorption rate was observed if volunteers remained lying or sitting during the experiment. Rectal dosing with valproic acid 520 mg dissolved in 4 ml suppositories, twice a day resulted in steady-state plasma concentrations of 50 to 100 µg · ml−1, within the therapeutic range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bruni J, Wilder BJ, Willmore LJ, Perchalski RJ, Villarreal HJ (1978) Steady-state kinetics of valproic acid in epileptic patients. Clin Pharmacol Ther 24: 324–332

    Google Scholar 

  • DeBlaey CJ, Polderman J (1978) Rationales in the design of rectal and vaginal delivery forms of drugs. In: Ariens, EJ (ed) Drug design. Academic Press, London

    Google Scholar 

  • Gugler R, Schell A, Eichelbaum M, Fröscher W, Schulz HV (1977) Disposition of valproic acid in man. Eur J Clin Pharmacol 12: 125–132

    Google Scholar 

  • Klotz U, Antonin KH (1977) Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 21: 736–743

    Google Scholar 

  • Loiseau P, Brachet A, Henry P (1975) Concentration of dipropylacetate in plasma. Epilepsia 16: 609–615

    Google Scholar 

  • Meunier H, Carraz G, Meunier V, Eymard M (1963) Proprietés pharmacodinamique de l'acide n-dipropylacetique. Therapie 18: 453–458

    Google Scholar 

  • Meijer JWA, Hessing-Brand L (1973) Determination of lower fatty acids, particulary the antiepileptic dipropyl-acetic acid, in biological materials by means of micro diffusion and gas chromatography. Clin Chim Acta 43: 215–222

    Google Scholar 

  • Moolenaar F, Schoonen AJM, Everts A, Huizinga T (1979) Absorption rate and bioavailability of paracetamol from fatty suppositories. Pharm Weekbl Sci Ed 1: 689–694

    Google Scholar 

  • Pinder RM, Brodgen RN, Speight TM, Avery GS (1977) Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13: 81–123

    Google Scholar 

  • Queveauviller A, Jund J (1951) La médication par voie rectale evite-t-elle la barrière hepatique? Ann Pharm Fr 9: 593–601

    Google Scholar 

  • Rutten-Kingma JJ (1977) Biofarmaceutisch onderzoek van suspensie-zetpillen. Ph. D. Thesis, University of Leiden, The Netherlands

    Google Scholar 

  • Schobben F, van der Kleijn E (1974) Pharmacokinetics of distribution and elimination of sodium di-n-propylacetate in mouse and dog. Pharm Weekbl 109: 33–41

    Google Scholar 

  • Schobben F, van der Kleijn E, Gabrieëls FJM (1975) Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol 8: 97–105

    Google Scholar 

  • Schoonen AJM, Moolenaar F, Haverschmidt C, Huizinga T (1976) The interphase transport of drugs from fatty suppository bases. Pharm. Weekbl 111: 585–590

    Google Scholar 

  • Simon D, Penry JK (1975) Sodium di-n-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsie 16: 549–573

    Google Scholar 

  • Sonnen AEH, Blom GF, Meijer JWA (1975) In: Schneider H, Janz D, Gardner-Thorpe C, Meinardi H, Sherwin AL (eds) Clinical pharmacology of anti-epileptic drugs. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Vajda FJE, Mihaly GW, Donnan GA, Bladin PF (1978) Rectal administration of sodium valproate in status epilepticus. Neurology 28: 897–899

    Google Scholar 

  • Vree TB, Van der Kleijn E, Knop HJ (1976) Rapid determination of 4-hydroxybutyric acid (Gamma OH) and 2-propylpentanoate (Depakine) in human plasma by means of gas-liquid chromatography. J. Chromatogr 121: 150–152

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Data have been presented in: F. Moolenaar, Ph. D. Thesis, Groningen, The Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moolenaar, F., Greving, W.J. & Huizinga, T. Absorption rate and bioavailability of valproic acid and its sodium salt from rectal dosage forms. Eur J Clin Pharmacol 17, 309–315 (1980). https://doi.org/10.1007/BF00625806

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00625806

Key words

Navigation